Palvella Therapeutics (PVLA) EBITDA Margin Growth (1y) (2015 - 2024)
Palvella Therapeutics (PVLA) EBITDA Margin Growth (1y) (2015 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Palvella Therapeutics |
1.49 Bn |
1.23 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2024 |
-446,112.00 |
| Sep 30, 2023 |
374,243.00 |
| Jun 30, 2023 |
32,882.00 |
| Mar 31, 2023 |
-64,453.00 |
| Sep 30, 2022 |
-323,234.00 |
| Jun 30, 2022 |
30,103.00 |
| Mar 31, 2022 |
-1,696.00 |
| Dec 31, 2021 |
55,354.00 |
| Sep 30, 2021 |
-10,407.00 |
| Jun 30, 2021 |
-56,602.00 |
| Mar 31, 2021 |
-700.00 |
| Dec 31, 2020 |
-67,353.00 |
| Sep 30, 2020 |
-47,254.00 |
| Jun 30, 2020 |
19,016.00 |
| Mar 31, 2020 |
8,893.00 |
| Dec 31, 2019 |
186,746.00 |
| Sep 30, 2019 |
7,563.00 |
| Jun 30, 2019 |
-26,006.00 |
| Mar 31, 2019 |
13,039.00 |
| Dec 31, 2018 |
-196,427.00 |
